ACCESSION: MSBNK-SMB_Measured-HSA015P0086002
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 29
COMMENT: RAW_SPEC {'EL06_pos_2163': {'bp': 78162.0, 'sum': 452765.0}, 'EL15_pos_2165': {'bp': 75446.0, 'sum': 452922.0}, 'EL18_pos_2164': {'bp': 69684.0, 'sum': 412485.0}, 'EL10_pos_2164': {'bp': 68963.0, 'sum': 409910.0}, 'EL09_pos_2165': {'bp': 67919.0, 'sum': 403646.0}, 'EL11_pos_2164': {'bp': 64084.0, 'sum': 414401.0}, 'EL24_pos_2170': {'bp': 63257.0, 'sum': 388637.0}, 'EL13_pos_2164': {'bp': 63115.0, 'sum': 411378.0}, 'EL08_pos_2163': {'bp': 62471.0, 'sum': 381295.0}, 'EL16_pos_2157': {'bp': 60419.0, 'sum': 379458.0}, 'EL02_pos_2236': {'bp': 58279.0, 'sum': 431480.0}, 'EL19_pos_2169': {'bp': 57160.0, 'sum': 404482.0}, 'EL23_pos_2158': {'bp': 50434.0, 'sum': 376362.0}, 'EL14_pos_2165': {'bp': 49980.0, 'sum': 384274.0}, 'EL16_pos_1910': {'bp': 48588.0, 'sum': 344650.0}, 'EL04_pos_1964': {'bp': 44106.0, 'sum': 368374.0}, 'EL06_pos_1916': {'bp': 43045.0, 'sum': 304253.0}, 'EL09_pos_1964': {'bp': 42026.0, 'sum': 364411.0}, 'EL08_pos_1959': {'bp': 40417.0, 'sum': 369392.0}, 'EL14_pos_1963': {'bp': 39282.0, 'sum': 361685.0}, 'EL17_pos_1954': {'bp': 37664.0, 'sum': 357329.0}, 'EL07_pos_1958': {'bp': 36541.0, 'sum': 347553.0}, 'EL01_pos_1966': {'bp': 36220.0, 'sum': 359037.0}, 'EL20_pos_1954': {'bp': 36020.0, 'sum': 350287.0}, 'EL18_pos_1964': {'bp': 32900.0, 'sum': 371739.0}, 'EL13_pos_1965': {'bp': 32054.0, 'sum': 342331.0}, 'EL23_pos_1966': {'bp': 31919.0, 'sum': 347075.0}, 'EL24_pos_1978': {'bp': 31301.0, 'sum': 317079.0}, 'EL15_pos_1966': {'bp': 30575.0, 'sum': 338651.0}}
COMMENT: RETENTION_TIME_STDEV 0.177
COMMENT: PRECURSOR_M/Z_RAW 86.097087
COMMENT: PRECURSOR_M/Z_STDEV 0.000027
COMMENT: PRECURSOR_IN_MS1 mz 86.096420; int 68.094; delta(ppm) 0.455629
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.094; C5H11N; [M+H]+; delta(ppm) -0.094019
COMMENT: PROPOSED_MF MS-FINDER 3.257; C5H11N; [M+H]+; delta(ppm) -0.102097
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.347; C5H11N; [M+H]+; delta(ppm) -0.102097
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H11N; [M+H]+; delta(ppm) -0.102097
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.429; AVFZOVWCLRSYKC-UHFFFAOYSA-N; [M+H]+; CN1CCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.983; NQRYJNQNLNOLGT-UHFFFAOYSA-N; [M+H]+; C1CCNCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.536; NISGSNTVMOOSJQ-UHFFFAOYSA-N; [M+H]+; C1CCC(C1)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.286; FQIMPUOQPQNHRX-UHFFFAOYSA-N; [M+H]+; N(=CC(C)C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.072; NQRYJNQNLNOLGT-UHFFFAOYSA-N; [M+H]+; Piperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.434; AVFZOVWCLRSYKC-UHFFFAOYSA-N; [M+H]+; N-Methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.100; NISGSNTVMOOSJQ-UHFFFAOYSA-N; [M+H]+; cyclopentanamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.892; FQIMPUOQPQNHRX-UHFFFAOYSA-N; [M+H]+; methyl(2-methylpropylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NQRYJNQNLNOLGT-UHFFFAOYSA-N; [M+H]+; Piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; AVFZOVWCLRSYKC-UHFFFAOYSA-N; [M+H]+; N-Methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.970; NISGSNTVMOOSJQ-UHFFFAOYSA-N; [M+H]+; cyclopentanamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.882; FQIMPUOQPQNHRX-UHFFFAOYSA-N; [M+H]+; methyl(2-methylpropylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.744; NQRYJNQNLNOLGT-UHFFFAOYSA-N; [M+H]+; piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.957; AVFZOVWCLRSYKC-UHFFFAOYSA-N; [M+H]+; 1-methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.579; NISGSNTVMOOSJQ-UHFFFAOYSA-N; [M+H]+; cyclopentanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.298; GBCKRQRXNXQQPW-UHFFFAOYSA-N; [M+H]+; N,N-dimethylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; RGHPCLZJAFCTIK-UHFFFAOYSA-N; [M+H]+; 2-methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; UVBBCQLPTZEDHT-UHFFFAOYSA-N; [M+H]+; pent-4-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.138; PUUULGNNRPBVBA-UHFFFAOYSA-N; [M+H]+; N-ethylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.127; BPIDLOWRIYHHBQ-UHFFFAOYSA-N; [M+H]+; pent-4-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.127; QKWULNOMHKBBLA-UHFFFAOYSA-N; [M+H]+; N-methylbut-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; RBRPAKDHMRWACJ-UHFFFAOYSA-N; [M+H]+; 2-methylbut-3-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; PMGNVDPARHYFIN-UHFFFAOYSA-N; [M+H]+; N-methylbut-3-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.062; ULEZWUGQDAQWPT-UHFFFAOYSA-N; [M+H]+; N-ethylcyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; NZZNMDNKJVUJAL-UHFFFAOYSA-N; [M+H]+; 2-ethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; GAZWKJNMLLGPKV-UHFFFAOYSA-N; [M+H]+; 2-ethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.013; IAWXHEPLJXAMSG-ONEGZZNKSA-N; [M+H]+; (E)-pent-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.898; KYINPWAJIVTFBW-UHFFFAOYSA-N; [M+H]+; 3-methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.892; RSUCYDXEFFBUSN-UHFFFAOYSA-N; [M+H]+; N-tert-butylmethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.892; VWJYDONMXDIHNY-NSCUHMNNSA-N; [M+H]+; (E)-pent-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; KTHMOBNDGBTCLB-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; YPIDADKMTAZBST-UHFFFAOYSA-N; [M+H]+; 2,4-dimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; BMVHDBKYVGUEIX-UHFFFAOYSA-N; [M+H]+; 2,3-dimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; LQNHRNOPWKZUSN-UHFFFAOYSA-N; [M+H]+; cyclobutylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; ZOGZOXRETBBBJI-UHFFFAOYSA-N; [M+H]+; 2-cyclopropylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.859; BFPMCZWKUSUMKE-UHFFFAOYSA-N; [M+H]+; 1-cyclopropyl-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; JSIGUUUNVYUWQT-UHFFFAOYSA-N; [M+H]+; N-methylcyclobutanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; IXCXVGWKYIDNOS-UHFFFAOYSA-N; [M+H]+; 1-cyclopropylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.853; ZAXBVBGWLMVNJN-UHFFFAOYSA-N; [M+H]+; 1-methylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.849; NIJMHZCHTZXLJX-UHFFFAOYSA-N; [M+H]+; (1-methylcyclopropyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.848; GNHDRVDLNQEOPA-UHFFFAOYSA-N; [M+H]+; 3-methylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.848; KYTQSTIMXRWCDS-UHFFFAOYSA-N; [M+H]+; N,1-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.848; BRWRRWXQMCPPRZ-UHFFFAOYSA-N; [M+H]+; (2-methylcyclopropyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.848; YYMQZXMSPLVJJN-UHFFFAOYSA-N; [M+H]+; 2-methylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; FVVGXRJNWIYMNJ-UHFFFAOYSA-N; [M+H]+; 1,2-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; RHJITQJBHCWZLJ-RFZPGFLSSA-N; [M+H]+; (1R,2R)-N,2-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; FJUWTTDYFTWJLY-QWWZWVQMSA-N; [M+H]+; (2R,3R)-2,3-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.782; NOBVTKCADZWKHR-UHFFFAOYSA-N; [M+H]+; N,2-dimethylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.778; PFCBHFDNVFQUJI-UHFFFAOYSA-N; [M+H]+; 3-methylbut-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.772; RLVVIGIYIMDCAU-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.767; IVYCMLREPMLLEO-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.766; JHTQHOGTBDMULK-RXMQYKEDSA-N; [M+H]+; (2S)-2-propan-2-ylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.719; NJTBJCGFHPFCQL-UHFFFAOYSA-N; [M+H]+; 3-methylbut-3-en-1-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C5H12N1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.323
MS$FOCUSED_ION: PRECURSOR_M/Z 86.096417
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-9000000000-a5e0abafcd723706cac0
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0497522 228.0676 56.050464 0.9991 80.30 -0.1068 27 f{C3H6N1}/4.93ppm,p-C2H6
  56.9650423 460.2584 56.965758 0.6320 123.98 0.6138 29 ?
  57.0337251 154.8804 57.034441 0.9643 45.99 0.3268 28 ?
  57.0700593 57.8668 57.070776 1.1039 26.28 -0.1435 24 f{C4H9}/3.20ppm,p-C1H3N1
  58.0653735 580.0034 58.066094 0.6372 106.26 0.8537 29 f{C3H8N1}/4.27ppm,p-C2H4
  67.0543675 134.1969 67.055109 1.1632 50.71 -0.0069 29 f{C5H7}/2.10ppm,p-H5N1
  69.0336182 112.6046 69.034361 0.9705 33.56 0.2938 25 ?
  69.0699993 67.8853 69.070742 1.1872 34.63 -0.2739 22 f{C5H9}/1.78ppm,p-H3N1
  70.0652546 156.4344 70.065998 0.7707 55.52 0.0335 29 f{C4H8N1}/1.84ppm,p-C1H4
  71.9520219 258.3530 71.952765 0.7366 51.81 0.7701 21 ?
  84.0444478 600.4504 84.045163 0.6425 232.97 -0.1493 29 ?
  84.0808555 64.2337 84.081571 1.4391 24.27 -0.1532 21 f{C5H10N1}/0.95ppm,p-H2
  84.9597610 653.9822 84.960473 0.4708 158.08 0.6478 29 ?
  85.0284723 559.0023 85.029184 0.4940 172.69 0.0443 29 ?
  85.0397264 78.3610 85.040438 1.1406 22.52 0.3636 23 ?
  85.0648246 171.5320 85.065536 0.9640 51.13 0.1579 29 ?
  86.0237044 206.9911 86.024411 0.8137 76.32 -0.2842 29 ?
  86.0600942 670.8969 86.060801 0.4764 203.78 0.0138 29 ?
  86.0964748 999.0000 86.097181 0.4065 27.42 1.0000 29 f{C5H12N1}/0.57ppm,p
  87.0441155 475.5518 87.044818 0.6548 141.82 0.0433 29 ?
  87.0553607 119.8259 87.056063 1.1946 41.25 0.0010 26 ?
  87.0917121 130.6004 87.092414 1.0678 56.08 -0.5402 28 ?
  88.0215377 162.1435 88.022235 1.2270 62.21 -0.0824 27 ?
  88.0757211 182.0496 88.076418 0.8175 68.18 -0.0082 28 ?
  102.9703356 56.8801 102.970921 1.0488 20.84 0.2338 21 ?
PK$NUM_PEAK: 25
PK$PEAK: m/z int. rel.int.
  56.049752 228.07 228
  56.965042 460.26 460
  57.033725 154.88 154
  57.070059 57.87 57
  58.065373 580.00 580
  67.054367 134.20 134
  69.033618 112.60 112
  69.069999 67.89 67
  70.065255 156.43 156
  71.952022 258.35 258
  84.044448 600.45 600
  84.080856 64.23 64
  84.959761 653.98 653
  85.028472 559.00 559
  85.039726 78.36 78
  85.064825 171.53 171
  86.023704 206.99 206
  86.060094 670.90 670
  86.096475 999.00 999
  87.044116 475.55 475
  87.055361 119.83 119
  87.091712 130.60 130
  88.021538 162.14 162
  88.075721 182.05 182
  102.970336 56.88 56
//
